Spectrum of benign breast disorders in a university hospital.
In a period of 2 years, 234 cases of benign breast disorder were studied. Breast pain and modularity was the commonest group (70.1%) followed by fibroadenoma (17.5%). Cyclical mastalgia (61.5%) is more common than non-cyclical mastalgia (38.5%). The age of the patients with cyclical mastalgia was significantly lesser than patients with non-cyclical mastalgia. Cyclical mastalgia was seen only in premenopausal females while non-cyclical mastalgia was also seen in postmenopausal females. Treatment with vitamin E showed 41% response rate with minimal side-effects while treatment with danazol showed 72.1% response rate but was associated with side-effects in one third of the patients.
Khanna
A K
AK
Institute of Medical Sciences, Banaras Hindu University, Varanasi.
Tapodar
J
J
Misra
M K
MK
D000328:Adult; D001941:Breast Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007194:India; D008597:Menstrual Cycle; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D010507:Periodicity; D014810:Vitamin E / Q000009:adverse effects / Q000627:therapeutic use
D004965:Estrogen Antagonists; D014810:Vitamin E; D003613:Danazol